Conflict of interest Author AA has received consulting fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz and Takeda
GLP-1 works by stimulating in the release of insulin in the body, a hormone that helps our cells use the sugar from our blood
Glucagon-like peptide-1 medications like semaglutide have helped millions lose weight, but injection discomfort remains a common barrier to consistent treatment
Promoting plant-based therapies for chronic kidney disease
Plastic syringes are not designed for long-term storage of peptides, and the risk of contamination and loss of sterility is high
Research shows it may be effective for improving insulin resistance, reducing body weight and lowering lipid levelssuggesting berberine as a natural option for supporting weight loss